Kim A. Carmichael, MD, FACP

Insulin is generally recommended as a second-line therapy when non-insulin agents alone or in combination at maximal tolerated doses fail to achieve glucose targets within a 3 to 6 month period.

Prediabetes is associated with serious metabolic issues, including insulin resistance, increased inflammatory mediators, greater hepatic glucose output, and endothelial vasodilator and fibrinolytic...

The most common neurologic symptom among patients with diabetes mellitus is a distal, symmetric, length-dependent sensorimotor polyneuropathy.

Although hemoglobin A1c is usually the best test to estimate the average glycemic control in patients with diabetes, it is unreliable in some clinical circumstances. In select patient populations, measuring...

In LADA, patients appear to have type 2 diabetes phenotypically. They do not, however, have an early requirement for insulin.

Insulin pumps are small, portable, external electronic devices that deliver insulin to the body in a continuous fashion for basal needs.

Although traditional insulins provide many options for treating patients with diabetes, some individuals require very high daily doses involving multiple shots that may cause local skin discomfort and...